Sorry, you need to enable JavaScript to visit this website.
Skip to main content

USP–NF Updates

Notices

USP–NF Compendial Notices are designed to inform stakeholders of the changing status of USP–NF monographs and general chapters, as well as other USP–NF standards-setting initiatives. 

Learn more

Updated Standards

Accelerated Revisions can be found through links on the Revision Bulletin and Interim Revision Announcement pages. Proposed revisions processed through USP’s Pending Monographs Program are available here.

Related Resources and Products

Compendial Tools
Compendial Tools

Compendial Tools are informational resources that may aid user in the application of USP standards. These tools are not official and do not affect the interpretation of any USP-developed compendium. These tools are not sufficient for determining whether an article complies with compendial requirements, and should not be used in that manner. These tools are used at the user's own discretion and risk.

Learn more

RS Catalog
Reference Standard Catalog

USP currently offers more than 3,500 Reference Standards to ensure quality in pharmaceutical development and manufacturing.

We now offer a growing catalogue of impurities through our Pharmaceutical Analytical Impurities (PAI) product line in addition to USP Reference Standards for impurities. Learn more.

Download Reference Standard Catalog

Download PAI Catalog

Education subscription bundle
USP–NF and USP Education subscription bundle

As of September 15, 2023, users can receive an 85% discount on USP Education Subscription when a USP–NF Subscription is purchased at regular price. This offer is available globally to anyone who has access to the store. The bundle is accessible through the USP Store search function and appears in the drop-down selections when either the USP–NF subscription or the USP Education Subscription is queried.

Access on USP Store

Standards Established through a Public Process

USP creates and continuously revises USP–NF standards through a unique public–private collaborative process, which involves pharmaceutical scientists in industry, academia, and government as well as other interested parties from anywhere in the world.

Warning Notice about USP–NF on Unauthorized Websites